Navigation Links
STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations
Date:8/26/2009

es.com

Significant recent transactions and events

The mutual recognition procedure for Oralair(R) (grass pollen desensitization tablet) started at an operational level in the second quarter and should lead to registration in most European countries by the end of 2009.

The phase IIb/III clinical study on the dust mite desensitization tablet for adult rhinitis proved positive and will support a European registration process. This study is a world first in dust mite immunotherapy, both in terms of its scale and the quality of its results.

Outlook for 2009

The 2009 sales growth guidance remains set at 10%. This level of growth should ensure operating profit remains at a level equivalent to 2008, against a background of increased R&D investments. Investments will remain at a high level, without calling into question the target of maintaining operating profitability above 15% and a positive free cash flow.

Lastly, the second half-year will be marked by a number of significant announcements. Five major phase II/III clinical study results are expected, of which three, if proving positive, will allow for registration into Oralair(R) phase III in the US, 3rd year of Oralair(R) long-term study in Europe and phase III Staloral(R) study on asthma in China.

ABOUT STALLERGENES

Stallergenes is a European biopharmaceutical company dedicated to desensitization therapies for the prevention and treatment of allergy-related respiratory diseases, e.g. rhinoconjunctivitis and allergic asthma. A pioneer and leader in sublingual desensitization treatments, Stallergenes devotes 21% (gross) of its sales to Research and Development and is actively involved in the development of a new therapeutic class: sublingual desensitization tablets.

In 2008, Stallergenes had sales of EUR 171 million and provided desensitization treatments to more than 50
'/>"/>

SOURCE Stallergenes
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
2. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
3. Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
4. Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit
5. Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%
6. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
7. Stallergenes: 2008: Sales Up 16% - Excellent Performance - Guidance Exceeded
8. STALLERGENES: 2008: Strong Performance
9. STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained
10. BIO International Convention 2009: Research Location Germany Presents Potential in Regenerative Medicine
11. Jatrophaworld Training 2009: 2nd Generation nonfood Biofuel crops Knowledge Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014  InterMune, Inc. (NASDAQ: ... second quarter 2014 financial results at the close of ... conference call and webcast will be hosted by InterMune ... Interested investors and others may participate in the ... (international), conference ID#21728775. A replay of the webcast and teleconference ...
(Date:7/28/2014)... , July 28, 2014 Research and Markets ... Size Analysis Market 2014-2018" report to their offering. ... size analysis is a technique used to determine the size ... liquid. It is crucial to analyze the size of particles ... particle size analysis is performed to determine the behavior and ...
(Date:7/26/2014)... Canada Endoscopy Visualization Systems Market ... the Canada Endoscopy Visualization Systems market. The report ... (in units) and average prices (in US dollars) ... Mid-Range Endoscopy Visualization Systems and Low-End Endoscopy Visualization ... . , The report also provides company shares ...
(Date:7/25/2014)... , July 25, 2014 Amgen (NASDAQ: ... today declared a $0.61 per share dividend for the ... on Sept. 5, 2014, to all stockholders of record ... 2014.  About Amgen Amgen is committed ... from serious illnesses by discovering, developing, manufacturing and delivering ...
Breaking Biology Technology:InterMune to Release Second Quarter Financial Results on August 6 2Global Particle Size Analysis Market 2014-2018 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3
... a better husband or wife, daughter or son, sister or ... into a confessional. I've just been thinking about the IT/business ... that relationship work, it's funny how frequently the conversation turns ... family. , ,"Oh great!" you're thinking. "Now you want me ...
... at the Ludwig Institute for Cancer Research , using ... a method to identify thousands of regulatory sequences in the ... , ,The purpose of the study was to find within ... starting points of the genes that determine how cells in ...
... needed to dispose of 1,100 used copier machines, it could ... to the company and a harder-to-calculate cost to the ... the machines by donating them to non-profit organizations. FedEx/Kinkos saved ... ever wondered about what happened to Scott McCallum, Aidmatrix is ...
Cached Biology Technology:Taking your work home 2Taking your work home 3NimbleGen identifies human genome sequences 2Internet charity link has a Wisconsin flavor in CEO Scott McCallum 2Internet charity link has a Wisconsin flavor in CEO Scott McCallum 3
(Date:7/28/2014)... cure for Alzheimer,s disease and other forms of dementia, ... finding treatment. , University of Washington bioengineers have a ... changes of the body,s normal proteins into a state ... heart disease, Type 2 diabetes and Lou Gehrig,s disease. ... from their normal state into an abnormally folded form ...
(Date:7/28/2014)... Jude Children,s Research Hospital study found that 73 percent ... their risk of developing metabolic syndrome and related health ... results appear in the current issue of the journal ... 1,598 adult survivors of childhood cancer in the study ... factors like high blood pressure, abdominal obesity, elevated triglyceride ...
(Date:7/28/2014)... -- Research and Markets has announced the ... 2014-2018" report to their offering. ... analyze biological data. These systems capture biological traits such ... and hand measurements from the subject and compare the ... purpose of a biometrics system is to identify and ...
Breaking Biology News(10 mins):New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 2Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 3Biometrics Market in Latin America 2014-2018 2
... Chemotherapy drugs, given intravenously, are the mainstay of the ... drugs effect a complete cure, while other times they ... those failures into successes? A team of scientists at ... the Biological Regulation Department, has come up with a ...
... Medicine studies of Hispanic farmworkers in North Carolina found that ... and that workers need more information about how to prevent ... as skin cancer. , Few studies have evaluated skin disease ... 59 farmworkers from Nash and Johnston Counties were examined by ...
... A promising new technique to ensure complete tumor removal ... issue of Radiology. , Researchers used light waves in ... region--to examine excised breast tissue and determine if the ... results. This technology has the potential to eliminate the ...
Cached Biology News:Predicting success 2Skin disease common among Hispanic farmworkers in North Carolina, research shows 2Terahertz imaging may reduce breast cancer surgeries 2
22 x 50 mm; No. 1 thickness range: 0.13 to 0.17 mm, suitable for work in histology, cytology, urinalysis and microbiology, precleaned, store at room temperature ...
... 100%,S-Adenosyl Methionine 2.5%,Adenosine ... <0.1%,Cystathionine ... <0.1%,Glutathione ... Assay Range: 0.1 ug/ml to 1 mg/ml,(0.26 M to 2.6 mM) ...
Panomer 9 oligodeoxynucleotides are random primers that are labeled at the 5' end with our proprietary QSY 7 dye and they are useful for assessing microarray spot morphology, hybridization potential ...
Topoisomerase I, isolated from wheat germ, is an enzyme capable of removing negative supercoils from covalently closed circular DNA (1)....
Biology Products: